Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Robinson

Showing results (71-80 of 73) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 73 results.
Archiv Der Pharmazie|July 31, 2001
Inactivation of protein farnesyltransferase by active-site-targeted dicarbonyl compoundsK J Okolotowicz, W J Lee, R F Hartman, et al.
Regulatory Toxicology and Pharmacology : RTP|June 18, 1998
Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans?R C Cattley, J DeLuca, C Elcombe, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 4, 2000
Lessons learned in applying the U.S. EPA proposed cancer guidelines to specific compoundsM E Andersen, M E Meek, G A Boorman, et al.
Pageof 8

Showing results (71-80 of 73) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 73 results.
Archiv Der Pharmazie|July 31, 2001
Inactivation of protein farnesyltransferase by active-site-targeted dicarbonyl compoundsK J Okolotowicz, W J Lee, R F Hartman, et al.
Regulatory Toxicology and Pharmacology : RTP|June 18, 1998
Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans?R C Cattley, J DeLuca, C Elcombe, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 4, 2000
Lessons learned in applying the U.S. EPA proposed cancer guidelines to specific compoundsM E Andersen, M E Meek, G A Boorman, et al.
Pageof 8